- Home
- LIND vs ARCT Comparison
LIND vs ARCT Comparison
Compare LIND & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIND
- ARCT
- Stock Information
- Founded
- LIND 1979
- ARCT 2013
- Country
- LIND United States
- ARCT United States
- Employees
- LIND N/A
- ARCT N/A
- Industry
- LIND Transportation Services
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- LIND Consumer Discretionary
- ARCT Health Care
- Exchange
- LIND Nasdaq
- ARCT Nasdaq
- Market Cap
- LIND 618.2M
- ARCT 526.5M
- IPO Year
- LIND N/A
- ARCT N/A
- Fundamental
- Price
- LIND $12.49
- ARCT $11.07
- Analyst Decision
- LIND Strong Buy
- ARCT Buy
- Analyst Count
- LIND 3
- ARCT 10
- Target Price
- LIND $16.67
- ARCT $35.25
- AVG Volume (30 Days)
- LIND 292.3K
- ARCT 2.1M
- Earning Date
- LIND 11-04-2025
- ARCT 11-07-2025
- Dividend Yield
- LIND N/A
- ARCT N/A
- EPS Growth
- LIND N/A
- ARCT N/A
- EPS
- LIND N/A
- ARCT N/A
- Revenue
- LIND $702,280,000.00
- ARCT $122,122,000.00
- Revenue This Year
- LIND $17.93
- ARCT N/A
- Revenue Next Year
- LIND $9.44
- ARCT $34.32
- P/E Ratio
- LIND N/A
- ARCT N/A
- Revenue Growth
- LIND 18.74
- ARCT N/A
- 52 Week Low
- LIND $7.45
- ARCT $8.04
- 52 Week High
- LIND $15.06
- ARCT $24.17
- Technical
- Relative Strength Index (RSI)
- LIND 49.48
- ARCT 31.90
- Support Level
- LIND $12.33
- ARCT $10.73
- Resistance Level
- LIND $12.99
- ARCT $12.10
- Average True Range (ATR)
- LIND 0.39
- ARCT 1.75
- MACD
- LIND 0.08
- ARCT -1.32
- Stochastic Oscillator
- LIND 62.26
- ARCT 12.60
About LIND Lindblad Expeditions Holdings Inc.
Lindblad Expeditions Holdings Inc provides expedition cruising and adventure travel services. The company operates in two segments: Lindblad and Land Experiences, of which Lindblad generates the vast majority of its revenue. It offers itineraries that feature up-close encounters with wildlife, nature, history, and culture, as well as promote guest empowerment and interactivity. It operates expeditions on intimately-scaled ships and interaction between guests, crew, and the teams of scientists, naturalists, researchers, and photographers that participate in the expeditions. Lindblad operates a fleet of twelve owned expedition ships and five seasonal charter vessels under the Lindblad brand.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.